A Long-term Safety Study of Esketamine Nasal Spray in Treatment-resistant Depression

Clinical trial NCT02782104 · COMPLETED

Trial details

NCT number: NCT02782104
Sponsor: Janssen Research & Development, LLC
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Depressive Disorder, Treatment-Resistant

Start date: 2016-06-09
Primary completion: 2022-12-30
Enrollment: 1148

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.